{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:52:56Z","timestamp":1791157976812,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60539-1","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:46:29Z","timestamp":1783176389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyaluronic acid\u2013functionalized Fe3O4 nanoparticles loaded with trans-chalcone: in vitro anticancer activity and lncRNA modulation in hepatocellular carcinoma cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Maryam","family":"Daghari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4238-0999","authenticated-orcid":false,"given":"Ali","family":"Salehzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Pourahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Yari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"3","key":"60539_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 74 (3), 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"Cancer J. Clin."},{"issue":"7","key":"60539_CR2","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.3390\/ijms23073778","volume":"23","author":"Z Sas","year":"2022","unstructured":"Sas, Z., Cendrowicz, E., Weinh\u00e4user, I. & Rygiel, T. P. Tumor microenvironment of hepatocellular carcinoma: Challenges and opportunities for new treatment options. Int. J. Mol. Sci. 23 (7), 3778. https:\/\/doi.org\/10.3390\/ijms23073778 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"60539_CR3","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/s12276-022-00864-3","volume":"54","author":"HY Min","year":"2022","unstructured":"Min, H. Y. & Lee, H. Y. Molecular targeted therapy for anticancer treatment. Exp. Mol. Med. 54 (10), 1670\u20131694. https:\/\/doi.org\/10.1038\/s12276-022-00864-3 (2022).","journal-title":"Exp. Mol. Med."},{"key":"60539_CR4","doi-asserted-by":"publisher","first-page":"1111991","DOI":"10.3389\/fphar.2023.1111991","volume":"14","author":"D Chen","year":"2023","unstructured":"Chen, D., Liu, X., Lu, X. & Tian, J. Nanoparticle drug delivery systems for synergistic delivery of tumor therapy. Front. Pharmacol. 14, 1111991. https:\/\/doi.org\/10.3389\/fphar.2023.1111991 (2023).","journal-title":"Front. Pharmacol."},{"issue":"3","key":"60539_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/17425247.2022.2047020","volume":"19","author":"D Stanicki","year":"2022","unstructured":"Stanicki, D., Vangijzegem, T., Ternad, I. & Laurent, S. An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery. Expert Opin. Drug Deliv. 19 (3), 321\u2013335. https:\/\/doi.org\/10.1080\/17425247.2022.2047020 (2022).","journal-title":"Expert Opin. Drug Deliv."},{"key":"60539_CR6","doi-asserted-by":"publisher","first-page":"100303","DOI":"10.1016\/j.apsadv.2022.100303","volume":"11","author":"RP Gambhir","year":"2022","unstructured":"Gambhir, R. P., Rohiwal, S. S. & Tiwari, A. P. Multifunctional surface functionalized magnetic iron oxide nanoparticles for biomedical applications: A review. Appl. Surf. Sci. Adv. 11, 100303. https:\/\/doi.org\/10.1016\/j.apsadv.2022.100303 (2022).","journal-title":"Appl. Surf. Sci. Adv."},{"issue":"12","key":"60539_CR7","doi-asserted-by":"publisher","first-page":"10296","DOI":"10.3390\/ijms241210296","volume":"24","author":"GN Iaconisi","year":"2023","unstructured":"Iaconisi, G. N. et al. Hyaluronic acid: A powerful biomolecule with wide-ranging applications\u2014A comprehensive review. Int. J. Mol. Sci. 24 (12), 10296. https:\/\/doi.org\/10.3390\/ijms241210296 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"60539_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.yexcr.2016.05.019","volume":"345","author":"RM Liu","year":"2016","unstructured":"Liu, R. M. et al. Hyaluronic acid enhances proliferation of human amniotic mesenchymal stem cells through activation of Wnt\/\u03b2-catenin signaling pathway. Exp. Cell Res. 345 (2), 218\u2013229 (2016).","journal-title":"Exp. Cell Res."},{"issue":"2","key":"60539_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/03008207.2018.1465053","volume":"60","author":"T Murakami","year":"2019","unstructured":"Murakami, T. et al. Hyaluronic acid promotes proliferation and migration of human meniscus cells via a CD44-dependent mechanism. Connect. Tissue Res. 60 (2), 117\u2013127. https:\/\/doi.org\/10.1080\/03008207.2018.1465053 (2019).","journal-title":"Connect. Tissue Res."},{"issue":"10","key":"60539_CR10","doi-asserted-by":"publisher","first-page":"2400513","DOI":"10.1002\/smtd.202400513","volume":"8","author":"Q Ouyang","year":"2024","unstructured":"Ouyang, Q., Zhao, Y., Xu, K., He, Y. & Qin, M. Hyaluronic acid receptor\u2010mediated nanomedicines and targeted therapy. Small Methods. 8 (10), 2400513. https:\/\/doi.org\/10.1002\/smtd.202400513 (2024).","journal-title":"Small Methods"},{"key":"60539_CR11","doi-asserted-by":"publisher","first-page":"900","DOI":"10.17179\/excli2018-1541","volume":"17","author":"M Abbastabar","year":"2018","unstructured":"Abbastabar, M., Sarfi, M., Golestani, A. & Khalili, E. lncRNA involvement in hepatocellular carcinoma metastasis and prognosis. EXCLI J. 17, 900. https:\/\/doi.org\/10.17179\/excli2018-1541 (2018).","journal-title":"EXCLI J."},{"issue":"3","key":"60539_CR12","first-page":"3076","volume":"8","author":"L Hua","year":"2015","unstructured":"Hua, L. et al. High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma. Int. J. Clin. Exp. Pathol. 8 (3), 3076 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"60539_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00432-017-2543-y","volume":"144","author":"J Ma","year":"2018","unstructured":"Ma, J., Li, T., Han, X. & Yuan, H. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 144 (2), 205\u2013214. https:\/\/doi.org\/10.1007\/s00432-017-2543-y (2018).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"10","key":"60539_CR14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/CAD.0000000000000807","volume":"30","author":"Y Ma","year":"2019","unstructured":"Ma, Y. et al. LncRNA ANRIL promotes cell growth, migration and invasion of hepatocellular carcinoma cells via sponging miR-144. Anti-Cancer Drugs. 30 (10), 1013\u20131021. https:\/\/doi.org\/10.1097\/CAD.0000000000000807 (2019).","journal-title":"Anti-Cancer Drugs"},{"issue":"1","key":"60539_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/cdd.2016.95","volume":"24","author":"Z Li","year":"2017","unstructured":"Li, Z. et al. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer. Cell. Death Differ. 24 (1), 59\u201371 (2017).","journal-title":"Cell. Death Differ."},{"key":"60539_CR16","doi-asserted-by":"crossref","unstructured":"Silva, G. et al. Trans-chalcone increases p53 activity via DNAJB1\/HSP40 induction and CRM1 inhibition. PLoS One 13(8), e0202263 (2018).","DOI":"10.1371\/journal.pone.0202263"},{"key":"60539_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phymed.2020.153373","volume":"80","author":"BTS Bortoleti","year":"2021","unstructured":"Bortoleti, B. T. S. et al. Trans-chalcone in duces death by autophagy mediated by p53 up-regulation and \u03b2-catenin down-regulation on human hepatocellular carcinoma HuH7. 5 cell line. Phytomedicine 80, 1\u20139. https:\/\/doi.org\/10.1016\/j.phymed.2020.153373 (2021).","journal-title":"Phytomedicine"},{"key":"60539_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.biopha.2016.11.047","volume":"85","author":"LFB Bortolotto","year":"2017","unstructured":"Bortolotto, L. F. B. et al. Cytotoxicity of trans-chalcone and licochalcone A against breast cancer cells is due to apoptosis induction and cell cycle arrest. Biomed. Pharmacother. 85, 425\u2013433. https:\/\/doi.org\/10.1016\/j.biopha.2016.11.047 (2017).","journal-title":"Biomed. Pharmacother."},{"issue":"23","key":"60539_CR19","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.3390\/molecules26237177","volume":"26","author":"M Rudrapal","year":"2021","unstructured":"Rudrapal, M. et al. Chalcone scaffolds, bioprecursors of flavonoids: Chemistry, bioactivities, and pharmacokinetics. Molecules 26 (23), 7177. https:\/\/doi.org\/10.3390\/molecules26237177 (2021).","journal-title":"Molecules"},{"issue":"6","key":"60539_CR20","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s10534-023-00516-7","volume":"36","author":"S Fekri Kohan","year":"2023","unstructured":"Fekri Kohan, S., Zamani, H. & Salehzadeh, A. Antibacterial potential and cytotoxic activity of iron oxide nanoparticles conjugated with thymol (Fe3O4@ Glu-Thymol) on breast cancer cells and investigating the expression of BAX, CASP8, and BCL-2 genes. Biometals 36 (6), 1273\u20131284. https:\/\/doi.org\/10.1007\/s10534-023-00516-7 (2023).","journal-title":"Biometals"},{"key":"60539_CR21","doi-asserted-by":"publisher","DOI":"10.1049\/iet-nbt.2018.5364","author":"A Salehzadeh","year":"2019","unstructured":"Salehzadeh, A., Naeemi, A. S., Khaknezhad, L., Moradi-Shoeili, Z. & Shandiz, S. A. S. Fe3O4\/Ag nanocomposite biosynthesized using Spirulina platensis extract and its enhanced anticancer efficiency. IET Nanobiotechnol. https:\/\/doi.org\/10.1049\/iet-nbt.2018.5364 (2019).","journal-title":"IET Nanobiotechnol."},{"issue":"1","key":"60539_CR22","first-page":"222","volume":"18","author":"T Ramezani","year":"2019","unstructured":"Ramezani, T., Nabiuni, M., Baharara, J., Parivar, K. & Namvar, F. Sensitization of resistance ovarian cancer cells to cisplatin by biogenic synthesized silver nanoparticles through p53 activation. Iran. J. Pharm. Res. IJPR 18 (1), 222 (2019).","journal-title":"Iran. J. Pharm. Res. IJPR"},{"key":"60539_CR23","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45. https:\/\/doi.org\/10.1093\/nar\/29.9.e45 (2001).","journal-title":"Nucleic Acids Res."},{"key":"60539_CR24","doi-asserted-by":"crossref","unstructured":"Najafipour, I. et al. Synthesis of Fe3O4@ MIL-101-OH\/Chitosan for adsorption and release of doxorubicin. Polymer Test. 142, 108659. https:\/\/doi.org\/10.1016\/j.polymertesting.2024.108659 (2025).","DOI":"10.1016\/j.polymertesting.2024.108659"},{"issue":"5","key":"60539_CR25","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1039\/D3NJ05411J","volume":"48","author":"MD Yilmaz","year":"2024","unstructured":"Yilmaz, M. D., Ozsamur, N. G. & Erbas-Cakmak, S. Catalytic investigation of hyaluronic acid-stabilized Ag nanoparticles as non-toxic nanocatalysts in the oxidation of morin. New J. Chem. 48 (5), 2341\u20132347. https:\/\/doi.org\/10.1039\/D3NJ05411J (2024).","journal-title":"New J. Chem."},{"issue":"2","key":"60539_CR26","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s13762-022-04679-7","volume":"20","author":"N Emami","year":"2023","unstructured":"Emami, N., Farhadian, M., Solaimany Nazar, A. R. & Tangestaninejad, S. Adsorption of cefixime and lamotrigine on HKUST-1\/ZIF-8 nanocomposite: Isotherms, kinetics models and mechanism. Int. J. Environ. Sci. Technol. 20 (2), 1645\u20131672. https:\/\/doi.org\/10.1007\/s13762-022-04679-7 (2023).","journal-title":"Int. J. Environ. Sci. Technol."},{"key":"60539_CR27","doi-asserted-by":"publisher","unstructured":"Shameli, K. et al. Green biosynthesis of silver nanoparticles using Curcuma longa tuber powder. Int. J. Nanomed. 5603\u20135610. https:\/\/doi.org\/10.2147\/IJN.S36786 (2012).","DOI":"10.2147\/IJN.S36786"},{"key":"60539_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.radphyschem.2017.12.002","volume":"145","author":"G Yakal\u0131","year":"2018","unstructured":"Yakal\u0131, G., Bi\u00e7er, A., Eke, C. & Cin, G. T. Solid state structural investigations of the bis (chalcone) compound with single crystal X-ray crystallography, DFT, gamma-ray spectroscopy and chemical spectroscopy methods. Radiat. Phys. Chem. 145, 89\u201396. https:\/\/doi.org\/10.1016\/j.radphyschem.2017.12.002 (2018).","journal-title":"Radiat. Phys. Chem."},{"issue":"2","key":"60539_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2174\/1568009614666140122160515","volume":"14","author":"D Jandial","year":"2014","unstructured":"Jandial, D. et al. Molecular targeted approaches to cancer therapy and prevention using chalcones. Curr. Cancer Drug Targets. 14 (2), 181\u2013200. https:\/\/doi.org\/10.2174\/1568009614666140122160515 (2014).","journal-title":"Curr. Cancer Drug Targets"},{"issue":"10","key":"60539_CR30","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/mc.22386","volume":"55","author":"G Silva","year":"2016","unstructured":"Silva, G., Marins, M., Fachin, A. L., Lee, S. H. & Baek, S. J. Anti-cancer activity of trans\u2010chalcone in osteosarcoma: Involvement of Sp1 and p53. Mol. Carcinog. 55 (10), 1438\u20131448. https:\/\/doi.org\/10.1002\/mc.22386 (2016).","journal-title":"Mol. Carcinog."},{"key":"60539_CR31","doi-asserted-by":"crossref","unstructured":"Silva, G. et al. Trans-chalcone increases p53 activity via DNAJB1\/HSP40 induction and CRM1 inhibition. PLoS One 13(8), e0202263. https:\/\/doi.org\/10.1371\/journal.pone.0202263 (2018).","DOI":"10.1371\/journal.pone.0202263"},{"key":"60539_CR32","doi-asserted-by":"crossref","unstructured":"Bortolotto, L. F. B. et al. Cytotoxicity of trans-chalcone and licochalcone A against breast cancer cells is due to apoptosis induction and cell cycle arrest. Biomed. Pharmacother. 85, 425\u2013433 (2017).","DOI":"10.1016\/j.biopha.2016.11.047"},{"key":"60539_CR33","doi-asserted-by":"crossref","unstructured":"Ramirez-Tagle, R. et al.  Chalcone-induced apoptosis through caspase-dependent intrinsic pathways in human hepatocellular carcinoma cells. Int. J. Mol. Sci. 17(2), 260. https:\/\/doi.org\/10.3390\/ijms17020260 (2016).","DOI":"10.3390\/ijms17020260"},{"key":"60539_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejmech.2017.02.002","volume":"129","author":"MM Hawash","year":"2017","unstructured":"Hawash, M. M., Kahraman, D. C., Eren, F., Atalay, R. C. & Baytas, S. N. Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics. Eur. J. Med. Chem. 129, 12\u201326. https:\/\/doi.org\/10.1016\/j.ejmech.2017.02.002 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"60539_CR35","doi-asserted-by":"crossref","unstructured":"da Silva Siqueira, E. et al. Trans-chalcone induces death by autophagy mediated by p53 up-regulation and \u03b2-catenin down-regulation on human hepatocellular carcinoma HuH7. 5 cell line. Phytomedicine 80, 153373. https:\/\/doi.org\/10.1016\/j.phymed.2020.153373 (2021).","DOI":"10.1016\/j.phymed.2020.153373"},{"key":"60539_CR36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.addr.2015.11.011","volume":"97","author":"F Dosio","year":"2016","unstructured":"Dosio, F., Arpicco, S., Stella, B. & Fattal, E. Hyaluronic acid for anticancer drug and nucleic acid delivery. Adv. Drug Deliv. Rev. 97, 204\u2013236. https:\/\/doi.org\/10.1016\/j.addr.2015.11.011 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"60539_CR37","doi-asserted-by":"crossref","unstructured":"Yu, K. S. et al. Receptor-meditated endocytosis by hyaluronic acid@ superparamagnetic nanovetor for targeting of CD44-overexpressing tumor cells. Nanomaterials 6(8), 149. https:\/\/doi.org\/10.3390\/nano6080149 (2016).","DOI":"10.3390\/nano6080149"},{"key":"60539_CR38","doi-asserted-by":"crossref","unstructured":"Komoto, T. T. et al. Exploring the therapeutic potential of trans-chalcone: Modulation of micrornas linked to breast cancer progression in MCF-7 cells. Int. J. Mol. Sci. 24(13), 10785. https:\/\/doi.org\/10.3390\/ijms241310785 (2023).","DOI":"10.3390\/ijms241310785"},{"key":"60539_CR39","doi-asserted-by":"crossref","unstructured":"Li, Z. et al.  LncRNA ANCR down-regulation promotes TGF-\u03b2-induced EMT and metastasis in breast cancer. Oncotarget 8(40), 67329.  10.18632\/oncotarget.18622 (2017).","DOI":"10.18632\/oncotarget.18622"},{"issue":"4","key":"60539_CR40","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.bbrc.2013.02.036","volume":"432","author":"L Zhu","year":"2013","unstructured":"Zhu, L. & Xu, P. C. Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression. Biochem. Biophys. Res. Commun. 432 (4), 612\u2013617. https:\/\/doi.org\/10.1016\/j.bbrc.2013.02.036 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"60539_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13000-015-0247-7","volume":"10","author":"L Lin","year":"2015","unstructured":"Lin, L., Gu, Z. T., Chen, W. H. & Cao, K. J. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis. Diagn. Pathol. 10 (1), 14. https:\/\/doi.org\/10.1186\/s13000-015-0247-7 (2015).","journal-title":"Diagn. Pathol."},{"key":"60539_CR42","doi-asserted-by":"crossref","unstructured":"Huang, M. D. et al.  Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of KLF2. J. Hematol. Oncol. 8(1), 50. https:\/\/doi.org\/10.1186\/s13045-015-0146-0 (2015).","DOI":"10.1186\/s13045-015-0153-1"},{"issue":"3","key":"60539_CR43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/15476286.2019.1708547","volume":"17","author":"Z Wen","year":"2020","unstructured":"Wen, Z. et al. LncRNA ANCR promotes hepatocellular carcinoma metastasis through upregulating HNRNPA1 expression. RNA Biol. 17 (3), 381\u2013394. https:\/\/doi.org\/10.1080\/15476286.2019.1708547 (2020).","journal-title":"RNA Biol."},{"issue":"3","key":"60539_CR44","first-page":"3076","volume":"8","author":"L Hua","year":"2015","unstructured":"Hua, L. et al. High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma. Int. J. Clin. Exp. Pathol. 8 (3), 3076 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60539-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60539-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60539-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:38:29Z","timestamp":1791157109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60539-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60539"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60539-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30782"}}